The global bronchopulmonary dysplasia (BPD) treatment market is set to experience significant growth, with market value expected to reach USD 385.6 million in 2023 and expand to USD 700.2 million by 2033, at a compound annual growth rate (CAGR) of 6.1% during the forecast period.
This growth is largely driven by the rising incidence of bronchopulmonary dysplasia, a chronic respiratory condition that primarily affects premature infants who have undergone supplemental oxygen therapy or mechanical ventilation. The increasing number of preterm births worldwide is further contributing to the growing demand for effective BPD treatments.
Bronchopulmonary dysplasia, also known as respiratory distress syndrome, commonly occurs in infants who have received breathing support due to underdeveloped lungs. Additionally, BPD can affect infants with abnormal lung development or those exposed to antenatal infections before birth, further highlighting the need for comprehensive treatment options.
The market demonstrated a steady growth rate with a 5.0% CAGR between 2018 and 2022, and this momentum is expected to continue as healthcare providers seek advanced therapies to manage chronic respiratory conditions in newborns.
The increased prevalence of bronchopulmonary dysplasia, a chronic respiratory illness intricately connected to the global rise in preterm births, is driving this significant market expansion. From 2018 to 2022, the sector had a solid historical CAGR of 5.0%, paving the way for the present increase.
Bronchopulmonary dysplasia, characterized by chronic respiratory challenges, predominantly affects premature infants who have undergone supplemental oxygen or mechanical ventilation, commonly associated with respiratory distress syndrome. Additionally, the condition may also manifest in infants with abnormal lung development or those exposed to antenatal infections before birth.
Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic era to focus on the growth and development of the Bronchopulmonary Dysplasia Treatment Market. The study features insights into the current growth dynamics and the major revenue reforms prevailing in the market along with the key takeaways from the forecast.
The team of analysts at Future Market Insights is focussing on research and market study to produce different Bronchopulmonary Dysplasia Treatment Market forecasts and predictions at both national and international levels. They have considered several leads of information about the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Bronchopulmonary Dysplasia Treatment Market.
Bronchopulmonary Dysplasia Treatment Market Key Players
The writer will create content on the general strategies of market players. Then will write the key players in the market are Airway Therapeutics LLC, Chiesi Farmaceutici SpA, Insmed Incorporated, MediPost Co., Ltd., Meridigen Biotech Co., Ltd, Syntrix Biosystems, Inc., Therabron Therapeutics, Inc.
Bronchopulmonary Dysplasia Treatment Market Segmentation
The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers gain a deeper understanding and unbiased opinion of the market. Numerous segmentations have been provided for this market based on:
Based on the drug type
- Bronchodilators
- Diuretics
- Antibiotics
- Steroids
- Immunomodulators
- Surfactant Homeostasis
Based on the therapy type
- Nitric Oxide Therapy
- Protein replacement therapy
- Stem Cell Therapy
- Supplemental Oxygen
Based on end-user
- Hospitals
- Nursing Homes
- Critical Care Centers
Product Segmentation
The investigation offers a top-to-bottom evaluation of clients’ journeys pertinent to the market and its segments. The study endeavors to assess the current and future development possibilities, undiscovered roads, and factors that shape their income potential in the global market by breaking it into such as its types, applications, and region-wise assessment.
Full in-depth analysis of the parent market
The analysts at FMI are dedicated to providing insights after extensive research and study. The study also includes estimations, projections, and evaluation of the market dynamics.
Important changes in market dynamics
The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future.
Segmentation Details of the Bronchopulmonary Dysplasia Treatment Market
- Former, ongoing, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
